<i>In Vitro</i> Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of <i>Candida glabrata</i> , <i>Candida auris</i> , <i>Cryptococcus neoformans</i> , and <i>Pneumocystis</i> spp

George Tetz(Human BioMolecular Research Institute), Victor Tetz(First Pavlov State Medical University of St. Petersburg), Daria Vikina, Margaret S. Collins(University of Cincinnati Medical Center)
Antimicrobial Agents and Chemotherapy
January 29, 2019
Cited by 23


Related Papers